Clinical Trial Update: F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating F-18 fluorothymidine PET imaging for early response evaluation in head and neck cancer patients; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Neoplasms
• Laryngeal Neoplasms
• Mouth Neoplasms
• Oropharyngeal Neoplasms

Snippet

Sponsor: University of Iowa | Conditions: Mouth Neoplasms, Oropharyngeal Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2017-10-03